Press Releases
 
Lexiscan Nuclear Stress Test Market - Trends and Segments 2016 - 2024

, 22 June 2018 -- Lexiscan Nuclear Stress Test Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Global Lexiscan Nuclear Stress Test Market: Snapshot

The need for ascertaining the health of arteries to identify coronary artery disease in patients who cannot perform an adequate level of exercise has led to the demand a nuclear imaging material such as lexiscan. The stress agent is particularly used in radionuclide myocardial perfusion imaging (MPI) and is approved by the U.S. Food and Drug Administration (FDA) for injecting it intravenously in patients to crate stress conditions equivalent to exercise. The inability of performing exercise can be attributed to various factors including arthritis, poor conditioning of the heart muscles, intake of blood pressure medications, or the use of devices such as pacemakers.

MPI consists of scanning heart muscles during rest and after the patient is injected lexiscan. Traces of radioactive material is used to act as a special imager before and after lexiscan is injected into the bloodstream. Comparing images before and after helps in determining the extent of damage of coronary, any arterial blockages, or any other heart defects. If the arteries of the patient undergoing test is narrowed they will respond less to the injection of lexiscan, and hence the scans processed by computer will show decreased blood flows in the affected arteries.

Obtain Report Details @ https://www.transparencymarketresearch.com/lexiscan-nuclear-stress-test-market.html

The need for MPI is usually recommended after a heart attack, which helps cardiologists guide decisions related to future treatment procedures such as angioplasty or coronary artery bypass surgeries. The rising prevalence of coronary artery disease in developed and developing countries is a key factor expected to boost the demand for cardiac nuclear lexiscan exercise stress test in the coming years.

Lexiscan or regadenoson is a stress agent, which typically works by increasing blood flow in the arteries of the heart. Lexiscan is specifically used for radionuclide myocardial perfusion imaging (MPI) in patients who are unable to bear adequate exercise stress. In this test, typically, patients are asked to walk on a treadmill or ride a stationary bicycle. The aim is to increase patient’s heart rate until it is adequately stressed.

The heart is a specified muscle and like other muscles in the body it needs oxygen and nutrients so that it can continuously pump blood throughout the body. Regadenoson is injected intravenously in preparation with a radiologic (X-ray) examination of blood flow through the myocardial perfusion imaging (MPI) nuclear stress test or coronary artery test.

On April 10, 2008, Lexiscan was approved by the U.S. Food and Drug Administration (FDA). It is marketed by Astellas Pharma. It is approved in the EU under the name Rapiscan. Currently, it is being marketed by GE Healthcare, which is being sold mainly in the United Kingdom (U.K.) and Germany.

Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=22805

MPI test is taking pictures of the blood flow in a patient’s heart. This test provides detailed anatomical images which can be used to diagnose and evaluate conditions in coronary artery disease. Coronary artery disease progresses when arteries become damaged or diseased. Usually, coronary arteries are damaged when they are accumulated with deposits called plaques. Shortness of breath is a usual indication of coronary artery disease. MPI test images can tell a doctor if a patient’s heart is bloated and can measure its overall functioning, for example ejection fraction.

The choice of lexiscan nuclear stress test modality depends on many factors. Some of the important factors are resting electrocardiogram (ECG), ability to perform exercise, and clinical signals performing the test.

The global lexiscan nuclear stress test market is driven by rise in incidence of coronary heart diseases. According to a recent analysis in the medical journal The Lancet, the number of people with peripheral arterial disease (PAD) has increased by 24% in the past ten years. Globally, millions of people are suffering with heart rhythm disorder atrial fibrillation also called AFib. Currently, nearly 2.7 million people in the U.S. have AFib. This number is expected to increase significantly due to rise in geriatric population.

The formation/accumulation of plaque in the arteries in the limbs is one of the major reasons that can cause heart attack or stroke. Other causes of rise in heart diseases are smoking, obesity, and changes in lifestyle. On the other hand, side effects and safety issues related to lexiscan nuclear stress test are projected to restrain the global lexiscan nuclear stress test market. People may experience side effects depending on individual conditions. The most common side effects that followed application of lexiscan test were headache, flushing, chest pain, nausea, feeling hot, dizziness, and nausea. Other factors likely to hamper market growth are rise in cost of overall treatment and surgeries.

Enquiry for Discount on this Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=22805

Key players operating in the lexiscan nuclear stress test market are Astellas Pharma, Inc. and GE Healthcare. Moreover, small number of players operate in this market at the regional level, especially in low to medium income parts of the world.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
Website: http://www.transparencymarketresearch.com

# # #


Submitted by hawer on Friday, 22 June 2018 at 8:37 PM
Category: Health Care & Medical
 
Related News

Toxicology Testing Services Market: In Silico Toxicology Testing Methods to Expand at Rapid Pace
Wednesday, 18 Jul 2018

Hemoglobin A1c Testing Devices Market will Expand at a CAGR of 10.3% Between 2013 and 2019
Wednesday, 18 Jul 2018

Enteral Feeding Devices Market: Europe Region Dominates the Global Market
Wednesday, 18 Jul 2018

Let Your Muscles Grow Stronger with HGH Sale in UK
Wednesday, 18 Jul 2018

Metabolomics Market- Current Trends, Opportunities 2024
Tuesday, 17 Jul 2018

Related Events

14th Public Relations and Communications Summit
Tuesday, 17 Jul 2018

10th Annual Detroit Regional Sports Medicine Symposium, Plymouth 2018
Wednesday, 18 Jul 2018

Mayo Clinic Neurology in Clinical Practice
Thursday, 19 Jul 2018

15th Annual Oncology Update CME Coverage of the 2018 ASCO Annual Meeting San Francisco, California
Saturday, 21 Jul 2018

Mastering Clinical Challenges and Emerging Therapies in IBD
Saturday, 21 Jul 2018

Latest News

Online Gambling Gets Safer and Easier With Fobet 88
Wednesday, 18 Jul 2018

Global Powder Coatings Industry Market: Technology, Applications, Growth and Status 2018
Wednesday, 18 Jul 2018

Tips For Men's Clothes And Styling
Wednesday, 18 Jul 2018

The Ultimate Guide to Get Best Water Filter
Wednesday, 18 Jul 2018

Drum pads
Wednesday, 18 Jul 2018

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2018
Today is Wednesday, 18 July 2018

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • 14th Public Relations and Communications Summit
  • Palo Alto Networks: Carrera por la Ciberseguridad de Protectia y Palo Alto Networks
  • The Medical Management of HIV or AIDS and Hepatitis
  • 10th Annual Detroit Regional Sports Medicine Symposium, Plymouth 2018
  • unbound London 2018: Tech Innovation Conference on 18 and 19 July 2018

  • Latest Jobs
    Sorry, there are currently no entries posted here.